Methodological challenges in the evaluation of prognostic factors in breast cancer
Many studies are carried out in an effort to find factors that help explain the large unexplained variation in prognosis of breast cancer patients. The principles of good study design and analysis are less well appreciated for prognostic factor studies than for therapeutic trials. The oncology literature is full of results from studies of varying quality, often with conflicting findings. As a consequence, despite the large number of studies, there is still uncertainty about the importance of most prognostic factors. Few recently proposed prognostic factors for breast cancer have become widely accepted. This paper reviews the important methodological issues underlying such research. These issues are illustrated with examples from published studies and recent reviews of papers published in cancer journals. Guidelines are proposed for conducting and evaluating prognostic factor studies which should improve the quality of research in this important area.
Key wordsprognostic studies study design sample size multiple regression analysis cutpoints continuous variables interaction analysis tests of predictiveness model validation meta-analysis
Unable to display preview. Download preview PDF.
- 8.Machin D, Campbell MJ, Fayers PM, Pinol APY: Sample Size Tables for Clinical Studies, 2nd edition. Blackwell, Oxford, 1997Google Scholar
- 17.Cox DR: Regression models and life-tables. J R Stat Soc B 34:187–220, 1972Google Scholar
- 27.Altman DG, Royston P: What do we mean by validating a prognostic model? Stat Med, in pressGoogle Scholar
- 33.Schwarzer G, Vach W, Schumacher M: On the misuses of artificial neural networks for prognostic factor and diagnostic classification in oncology. University of Freiburg Technical Report No. 46, 1997Google Scholar
- 50.Gardner MJ, Altman DG (eds) Statistics with Confidence. British Medical Journal, London, 1989Google Scholar